Real-world effectiveness of intravenous belimumab in adults with systemic lupus erythematosus: results of the observational OBSErve study in the Russian Federation

Real-world effectiveness of intravenous belimumab in adults with systemic lupus erythematosus: results of the observational OBSErve study in the Russian Federation

Abstract Background The real-world effectiveness of intravenous (IV) belimumab in treating systemic lupus erythematosus (SLE) has been demonstrated in various countries through the OBSErve (evaluation Of use of Belimumab in clinical practice SEttings) program. Here we describe the clinical effective...

Full description

Saved in:
Bibliographic Details
Main Authors: Alexander Mikhailovich Lila, Elena Aleksandrovna Aseeva, Alyona Igorevna Zagrebneva, Irina Borisovna Vinogradova, Ruzana Ramilovna Samigullina, Munther Khamashta, Tamer Elfishawy, Lindsey Teichman, Debora dos Santos, Juliana Queiroz, Larisa Alexandrovna Kniazeva, Saeed Noibi
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Rheumatology
Subjects:
Belimumab
Biologic drugs
Cohort study
Disease activity
Disease modification
Glucocorticoids
Online Access:https://doi.org/10.1186/s41927-024-00452-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s41927-024-00452-0

Similar Items